These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Epstein-Barr virus in Burkitt's lymphoma: the missing link. Stebbing J; Bower M Lancet Oncol; 2009 Apr; 10(4):430. PubMed ID: 19341975 [No Abstract] [Full Text] [Related]
29. A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib. Lee CS; Rattu MA; Kim SS J Oncol Pharm Pract; 2016 Feb; 22(1):92-104. PubMed ID: 25425007 [TBL] [Abstract][Full Text] [Related]
30. The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Zou YX; Zhu HY; Li XT; Xia Y; Miao KR; Zhao SS; Wu YJ; Wang L; Xu W; Li JY Hematol Oncol; 2019 Oct; 37(4):392-400. PubMed ID: 31420873 [TBL] [Abstract][Full Text] [Related]
31. EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab. van de Langerijt B; Doorduijn JK; Lam KH; van den Bent MJ J Neurol; 2011 May; 258(5):944-5. PubMed ID: 21136270 [No Abstract] [Full Text] [Related]
32. The use of ibrutinib in chronic lymphocytic leukemia. Damon LE Clin Adv Hematol Oncol; 2016 Mar; 14(3):154-6. PubMed ID: 27058026 [No Abstract] [Full Text] [Related]